| MeSH term | MeSH ID | Detail |
|---|---|---|
| Mitochondrial Diseases | D028361 | 25 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
Total
3
Palmitoylcarnitine
Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine
NCBI Entrez Crosslinks
All references with Palmitoylcarnitine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| O'Hagan DT et al. | Nasal absorption enhancers for biosynthetic human growth hormone in rats. | 1990 | Pharm. Res. | pmid:2395807 |
| Kanaley JA et al. | Hyperinsulinemia and skeletal muscle fatty acid trafficking. | 2013 | Am. J. Physiol. Endocrinol. Metab. | pmid:23820622 |
| Gupte AA et al. | High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance. | 2013 | Endocrinology | pmid:23709089 |
| Moreno-Sánchez R et al. | Influence of NAD-linked dehydrogenase activity on flux through oxidative phosphorylation. | 1990 | Biochem. J. | pmid:2363681 |
| Ellis CJ et al. | Myoglobinuria: the importance of reaching a firm diagnosis--a patient with defective fatty acid oxidation. | 1990 | Postgrad Med J | pmid:2362895 |
| Perevoshchikova IV et al. | Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. | 2013 | Free Radic. Biol. Med. | pmid:23583329 |
| Dixen K et al. | ERRγ enhances UCP1 expression and fatty acid oxidation in brown adipocytes. | 2013 | Obesity (Silver Spring) | pmid:23404793 |
| pmid:23345165 | ||||
| pmid:2331016 | ||||
| pmid:23224819 | ||||
| pmid:2306788 | ||||
| Shi X et al. | Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity. | 2012 | J. Lipid Res. | pmid:22904346 |
| pmid:2288768 | ||||
| Adams RJ et al. | In vitro effects of palmitylcarnitine on cardiac plasma membrane Na,K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport. | 1979 | J. Biol. Chem. | pmid:227894 |
| Jørgensen W et al. | Progression of type 2 diabetes in GK rats affects muscle and liver mitochondria differently: pronounced reduction of complex II flux is observed in liver only. | 2012 | Am. J. Physiol. Endocrinol. Metab. | pmid:22713504 |
| pmid:22678774 | ||||
| Satyamoorthy K and Perchellet JP | Inhibition of mouse skin tumor promotion by adriamycin and daunomycin in combination with verapamil or palmitoylcarnitine. | 1990 | Cancer Lett. | pmid:2265412 |
| pmid:22622056 | ||||
| Arduini A et al. | Palmitoyl-L-carnitine, a metabolic intermediate of the fatty acid incorporation pathway in erythrocyte membrane phospholipids. | 1990 | Biochem. Biophys. Res. Commun. | pmid:2256917 |
| Tonazzi A et al. | Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. | 2012 | Biochim. Biophys. Acta | pmid:22365929 |